Progressive Care Gains SEC Reporting Status
April 12 2022 - 7:52AM
InvestorsHub NewsWire
Progressive Care announced effective
April 11, 2022, its Registration Statement on Form 10 filed with
the U.S. Securities and Exchange
Miami, FL -- April 12, 2022 -- InvestorsHub NewsWire --
Progressive Care, Inc. (OTCQB:
RXMD) (the “Company”), a personalized healthcare services and
technology provider, today announced that, effective April 11,
2022, its Registration Statement on Form 10 filed with the U.S.
Securities and Exchange (the “SEC”) to register its shares of
common stock under Section 12(g) of the Securities Exchange Act of
1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K, in addition to complying with all other
obligations under the Exchange Act. In addition, management and
certain shareholders are subject to the beneficial ownership
reporting requirements of Section 13 and 16 of the Exchange
Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the
Company, said, “For me, it was always important to have the Company
become fully reporting with the SEC. I know how critical it is for
individual and institutional investors to have the Company file its
financial reports with the SEC as it provides a higher level of
confidence in the information reported by the Company and a
superior level of transparency. I believe that the Company’s
compliance with the Exchange Act will ultimately help drive
shareholder value and enable us to access higher quality
institutional capital. We remain committed to strong corporate
governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Oct 2023 to Oct 2024